188 related articles for article (PubMed ID: 38032931)
1. A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family.
Cámara-Checa A; Perin F; Rubio-Alarcón M; Dago M; Crespo-García T; Rapún J; Marín M; Cebrián J; Gómez R; Bermúdez-Jiménez F; Monserrat L; Tamargo J; Caballero R; Jiménez-Jáimez J; Delpón E
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2305135120. PubMed ID: 38032931
[TBL] [Abstract][Full Text] [Related]
2. Identification of the molecular site of ivabradine binding to HCN4 channels.
Bucchi A; Baruscotti M; Nardini M; Barbuti A; Micheloni S; Bolognesi M; DiFrancesco D
PLoS One; 2013; 8(1):e53132. PubMed ID: 23308150
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.
Erlenhardt N; Kletke O; Wohlfarth F; Komadowski MA; Clasen L; Makimoto H; Rinné S; Kelm M; Jungen C; Decher N; Meyer C; Klöcker N
Pflugers Arch; 2020 Dec; 472(12):1733-1742. PubMed ID: 33095298
[TBL] [Abstract][Full Text] [Related]
4. A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia.
Baruscotti M; Bucchi A; Milanesi R; Paina M; Barbuti A; Gnecchi-Ruscone T; Bianco E; Vitali-Serdoz L; Cappato R; DiFrancesco D
Eur Heart J; 2017 Jan; 38(4):280-288. PubMed ID: 28182231
[No Abstract] [Full Text] [Related]
5. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
[TBL] [Abstract][Full Text] [Related]
6. Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.
Li CH; Zhang Q; Teng B; Mustafa SJ; Huang JY; Yu HG
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C355-62. PubMed ID: 17977941
[TBL] [Abstract][Full Text] [Related]
7. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model.
Zicha S; Fernández-Velasco M; Lonardo G; L'Heureux N; Nattel S
Cardiovasc Res; 2005 Jun; 66(3):472-81. PubMed ID: 15914112
[TBL] [Abstract][Full Text] [Related]
8. Targeting miR-423-5p Reverses Exercise Training-Induced HCN4 Channel Remodeling and Sinus Bradycardia.
D'Souza A; Pearman CM; Wang Y; Nakao S; Logantha SJRJ; Cox C; Bennett H; Zhang Y; Johnsen AB; Linscheid N; Poulsen PC; Elliott J; Coulson J; McPhee J; Robertson A; da Costa Martins PA; Kitmitto A; Wisløff U; Cartwright EJ; Monfredi O; Lundby A; Dobrzynski H; Oceandy D; Morris GM; Boyett MR
Circ Res; 2017 Oct; 121(9):1058-1068. PubMed ID: 28821541
[TBL] [Abstract][Full Text] [Related]
9. Mutation in S6 domain of HCN4 channel in patient with suspected Brugada syndrome modifies channel function.
Biel S; Aquila M; Hertel B; Berthold A; Neumann T; DiFrancesco D; Moroni A; Thiel G; Kauferstein S
Pflugers Arch; 2016 Oct; 468(10):1663-71. PubMed ID: 27553229
[TBL] [Abstract][Full Text] [Related]
10. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.
Nof E; Luria D; Brass D; Marek D; Lahat H; Reznik-Wolf H; Pras E; Dascal N; Eldar M; Glikson M
Circulation; 2007 Jul; 116(5):463-70. PubMed ID: 17646576
[TBL] [Abstract][Full Text] [Related]
11. Control of heart rate by cAMP sensitivity of HCN channels.
Alig J; Marger L; Mesirca P; Ehmke H; Mangoni ME; Isbrandt D
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12189-94. PubMed ID: 19570998
[TBL] [Abstract][Full Text] [Related]
12. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.
Stieber J; Herrmann S; Feil S; Löster J; Feil R; Biel M; Hofmann F; Ludwig A
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15235-40. PubMed ID: 14657344
[TBL] [Abstract][Full Text] [Related]
13. cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control.
Schweizer PA; Duhme N; Thomas D; Becker R; Zehelein J; Draguhn A; Bruehl C; Katus HA; Koenen M
Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):542-52. PubMed ID: 20693575
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease.
Weigl I; Geschwill P; Reiss M; Bruehl C; Draguhn A; Koenen M; Sedaghat-Hamedani F; Meder B; Thomas D; Katus HA; Schweizer PA
Biochem Biophys Res Commun; 2019 Oct; 519(1):141-147. PubMed ID: 31481236
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Analyses of Novel HCN4 Gene Mutations.
Möller M; Silbernagel N; Wrobel E; Stallmayer B; Amedonu E; Rinné S; Peischard S; Meuth SG; Wünsch B; Strutz-Seebohm N; Decher N; Schulze-Bahr E; Seebohm G
Cell Physiol Biochem; 2018; 49(3):1197-1207. PubMed ID: 30196304
[TBL] [Abstract][Full Text] [Related]
16. Pacemaker activity of the human sinoatrial node: effects of HCN4 mutations on the hyperpolarization-activated current.
Verkerk AO; Wilders R
Europace; 2014 Mar; 16(3):384-95. PubMed ID: 24569893
[TBL] [Abstract][Full Text] [Related]
17. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias.
Michels G; Er F; Khan I; Südkamp M; Herzig S; Hoppe UC
Circulation; 2005 Feb; 111(4):399-404. PubMed ID: 15687126
[TBL] [Abstract][Full Text] [Related]
18. Associated changes in HCN2 and HCN4 transcripts and I(f) pacemaker current in myocytes.
Zhang Q; Huang A; Lin YC; Yu HG
Biochim Biophys Acta; 2009 May; 1788(5):1138-47. PubMed ID: 19236845
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.
Liao Z; Lockhead D; Larson ED; Proenza C
J Gen Physiol; 2010 Sep; 136(3):247-58. PubMed ID: 20713547
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic regulation of HCN4 channel requires protein association with β2-adrenergic receptor.
Greene D; Kang S; Kosenko A; Hoshi N
J Biol Chem; 2012 Jul; 287(28):23690-7. PubMed ID: 22613709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
